KR101233081B1 - 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 - Google Patents
재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 Download PDFInfo
- Publication number
- KR101233081B1 KR101233081B1 KR1020120044800A KR20120044800A KR101233081B1 KR 101233081 B1 KR101233081 B1 KR 101233081B1 KR 1020120044800 A KR1020120044800 A KR 1020120044800A KR 20120044800 A KR20120044800 A KR 20120044800A KR 101233081 B1 KR101233081 B1 KR 101233081B1
- Authority
- KR
- South Korea
- Prior art keywords
- recombinant virus
- virus
- recombinant
- gene
- beasybac
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 112
- 238000013320 baculovirus expression vector system Methods 0.000 title abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 57
- 241000238631 Hexapoda Species 0.000 claims description 30
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- 239000013598 vector Substances 0.000 claims description 17
- 241000701447 unidentified baculovirus Species 0.000 claims description 13
- 238000012546 transfer Methods 0.000 claims description 11
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims 1
- 230000017105 transposition Effects 0.000 abstract description 6
- 108700005090 Lethal Genes Proteins 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 50
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 11
- 230000003612 virological effect Effects 0.000 description 9
- 101710182846 Polyhedrin Proteins 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 230000006801 homologous recombination Effects 0.000 description 6
- 238000002744 homologous recombination Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 4
- 108700039887 Essential Genes Proteins 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 241001207171 Goja Species 0.000 description 2
- 101710141347 Major envelope glycoprotein Proteins 0.000 description 2
- 102000008579 Transposases Human genes 0.000 description 2
- 108010020764 Transposases Proteins 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 241001203868 Autographa californica Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 241001608896 Cotesia vestalis Species 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 1
- 101100175482 Glycine max CG-3 gene Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/866—Baculoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
*도2는 이지박 발현계 (EasyBac System)의 재조합바이러스 생산 원리를 나타낸 것이다.
도3은 재조합바이러스 비이지박 (bEasyBac)의 제작 과정을 나타낸 것이다.
도4a는 재조합바이러스 비이지박 (bEasyBac)이 곤충 세포주 내에서 증식할 수 없음을 증명하기 위해, 증식이 가능한 재조합바이러스 (bTenLacZ)를 대조구로 하여 곤충 세포의 증식률을 비교한 것이다.
도4b는 도4a에 있어서, 두 재조합 바이러스 유전자의 곤충 세포주 내에서의 엠알엔에이(mRNA)생성여부를 알티피씨알 (RT-PCR)로 확인한 결과이다.
도5a는 재조합바이러스 비이지박 (bEasyBac)의 외래 단백질 발현 효율을 다른 발현계인 비에씨고자 (bAcGOZA)와 비교한 결과이다.
도5b는 도5a에 있어서, 두 발현계의 외래 단백질 발현 효율 차이가 재조합 바이러스의 순수율에 있음을 피씨알 (PCR)로 확인한 결과이다.
도6a는 이지박 발현계(EasyBac System)를 이용한 재조합 바이러스의 대량생산 여부를 인시추 어쎄이 (in situ Assay)로 증명한 결과이고, 도6b는 도6a의 재조합바이러스들의 외래단백질 생성을 에스디에스 피에이지(SDS-PAGE)로 확인한 결과이다.
Claims (2)
- 외래 유전자가 도입된 재조합 바이러스를 동시에 대량 생산하는 베큘로바이러스 발현 방법에 있어서,
상기 베큘로바이러스가 곤충 세포주(Sf9)내에서 증식할 수 없는 비이지박(bEasyBac)(기탁번호 : KCTC 11499BP)인 것이 특징인 베큘로바이러스 발현 방법.
- 제1항에 있어서, 상기 외래 유전자는 EGFP 유전자이며 이를 트랜스퍼벡터 pDualBac(5,964 bp)내에 삽입하는 것이 특징인 베큘로바이러스 발현 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120044800A KR101233081B1 (ko) | 2012-04-27 | 2012-04-27 | 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120044800A KR101233081B1 (ko) | 2012-04-27 | 2012-04-27 | 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090039373A Division KR101223577B1 (ko) | 2009-05-06 | 2009-05-06 | 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120047889A KR20120047889A (ko) | 2012-05-14 |
KR101233081B1 true KR101233081B1 (ko) | 2013-02-14 |
Family
ID=46266444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120044800A KR101233081B1 (ko) | 2012-04-27 | 2012-04-27 | 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101233081B1 (ko) |
-
2012
- 2012-04-27 KR KR1020120044800A patent/KR101233081B1/ko active IP Right Grant
Non-Patent Citations (3)
Title |
---|
Biotechnol. Lett., Vol. 23, pp. 575~582 (2001) * |
Int. J. Indust. Entomol., Vol. 2, No. 2, pp. 155~160 (2001) * |
J. Virol., Vol. 67, No. 8, pp. 4566~4579 (1993) * |
Also Published As
Publication number | Publication date |
---|---|
KR20120047889A (ko) | 2012-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4597188B2 (ja) | 多タンパク質適用のための新規発現ツール | |
Pearson et al. | Identification of the Lymantria dispar nucleopolyhedrovirus envelope fusion protein provides evidence for a phylogenetic division of the Baculoviridae | |
Hitchman et al. | Optimizing the baculovirus expression vector system | |
WO2003074714A1 (en) | Baculovirus expression system | |
EP2358883B1 (en) | Baculoviral vectors | |
Ke et al. | Autographa californica multiple nucleopolyhedrovirus ac66 is required for the efficient egress of nucleocapsids from the nucleus, general synthesis of preoccluded virions and occlusion body formation | |
Chen et al. | Autographa californica multiple nucleopolyhedrovirus odv-e25 (Ac94) is required for budded virus infectivity and occlusion-derived virus formation | |
Pijlman et al. | Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript | |
CN102286534B (zh) | 表达多外源基因的昆虫生物反应器及其构建方法和应用 | |
Liu et al. | Autographa californica multiple nucleopolyhedrovirus ac53 plays a role in nucleocapsid assembly | |
KR101223577B1 (ko) | 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 | |
Wang et al. | Influences of chitinase gene deletion from BmNPV on the cell lysis and host liquefaction | |
KR101233081B1 (ko) | 재조합바이러스 비이지박 (bEasyBac)과 이를 이용한 베큘로바이러스 발현벡터계 | |
Hilton et al. | A bacmid approach to the genetic manipulation of granuloviruses | |
Lin et al. | ac109 is required for the nucleocapsid assembly of Autographa californica multiple nucleopolyhedrovirus | |
Tang et al. | Characterization of a Bombyx mori nucleopolyhedrovirus with Bmvp80 disruption | |
Roy et al. | Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectives | |
Tao et al. | Functional characterization of Autographa californica multiple nucleopolyhedrovirus ORF43 and phenotypic changes of ORF43-knockout mutant | |
Wang et al. | Bombyx mori nucleopolyhedrovirus protein Bm11 is involved in occlusion body production and occlusion-derived virus embedding | |
Li et al. | The FP25K acts as a negative factor for the infectivity of AcMNPV budded virus | |
US6106825A (en) | Entomopoxvirus-vertebrate gene delivery vector and method | |
US6806064B2 (en) | Baculovirus enhancer-like sequence | |
Guo et al. | Open reading frame 60 of the Bombyx mori nucleopolyhedrovirus plays a role in budded virus production | |
Lihoradova et al. | The Homingbac baculovirus cloning system: An alternative way to introduce foreign DNA into baculovirus genomes | |
Li et al. | Bombyx mori nucleopolyhedrovirus Bm46 is essential for efficient production of infectious BV and nucleocapsid morphogenesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
PA0107 | Divisional application |
Comment text: Divisional Application of Patent Patent event date: 20120427 Patent event code: PA01071R01D |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20120524 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20121109 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130207 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130208 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20160112 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20160112 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170123 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20170123 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180129 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20180129 Start annual number: 6 End annual number: 6 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20190828 |
|
FPAY | Annual fee payment |
Payment date: 20190828 Year of fee payment: 7 |
|
PR0401 | Registration of restoration |
Patent event code: PR04011E01D Patent event date: 20190828 Comment text: Registration of Restoration |
|
PR1001 | Payment of annual fee |
Payment date: 20190828 Start annual number: 7 End annual number: 7 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20200203 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20200203 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20210201 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20220621 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20240125 Start annual number: 12 End annual number: 12 |